Search Grant Opportunities

Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed)

ID: RFA-CA-21-054 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

Posted: Aug. 31, 2021, 12:00 a.m. EDT
The TBEL program aims to integrate basic and translational cancer research concepts to examine the direct causal relationships and interactions of an early lesion, its microenvironment and host-systemic factors as co-organizers of tumor initiation (or suppression) and malignant progression. The ultimate goals of the TBEL program are to further understand the biological and pathophysiological mechanisms driving or restraining precancers and early cancers and facilitate biology-backed precision prevention approaches. The FOA will utilize the U54 (Specialized Center--Cooperative Agreements) activity code. Each TBEL Center shall have a unique thematic focus and be structured to test hypotheses that bridge basic and translational research in a synergistic and iterative fashion. Collectively, TBEL Centers will operate as a network that will inform future, rationally-design modes of intervention that are founded on strong biological mechanisms and be comprehensive, multi-dimensional, and appropriately tailored to the degree of malignant potential of an early lesion.
Posted: May 4, 2021, 12:00 a.m. EDT
Posted: May 4, 2021, 12:00 a.m. EDT

Overview

Category of Funding
Education
Health
Funding Instruments
Cooperative Agreement
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 8/31/21 the National Institutes of Health posted grant opportunity RFA-CA-21-054 for Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed). The grant will be issued under grant program 93.394 Cancer Detection and Diagnosis Research.

Timing

Posted Date
Aug. 31, 2021, 12:00 a.m. EDT
Closing Date
Nov. 2, 2021, 12:00 a.m. EDT Past Due
Last Updated
Aug. 31, 2021, 1:39 p.m. EDT
Version
1
Archive Date
Dec. 8, 2021

Eligibility

Eligible Applicants
County governments
Independent school districts
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
City or township governments
Special district governments
Private institutions of higher education
State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Award Sizing

Ceiling
$1,000,000
Floor
Not Listed
Estimated Program Funding
Not Provided
Estimated Number of Grants
Not Listed

Contacts

Contact
National Institutes of Health
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541

Documents

Posted documents for RFA-CA-21-054

Grant Awards

Grants awarded through RFA-CA-21-054

Incumbent or Similar Grants

Similar Active Opportunities

Open grant opportunities similar to RFA-CA-21-054

Experts for Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed)

Recommended subject matter experts available for hire